Evidence map›Paper›PMID 41217062›Full record

ArticleThe journal of physical chemistry. B2025

Design Rules for Expanding PAM Compatibility in CRISPR-Cas9 from the VQR, VRER and EQR variants.

Francisco Vieyra, Chinmai Pindi, George P Lisi, Uriel N Morzan, Giulia Palermo

Abstract read
PubMed Publisher
In one paragraph

Article in The journal of physical chemistry. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Francisco VieyraDepartment of Inorganic, Analytical & Chemical Physics, University of Buenos Aires, Buenos Aires C1053ABH, Argentina.
Chinmai PindiDepartment of Bioengineering, University of California Riverside, 900 University Avenue, Riverside, California 52512, United States.
George P LisiDepartment of Molecular Biology, Cell Biology & Biochemistry, Brown University, Providence, Rhode Island 02912, United States.ORCID 0000-0001-8878-5655
Uriel N MorzanDepartment of Inorganic, Analytical & Chemical Physics, University of Buenos Aires, Buenos Aires C1053ABH, Argentina.ORCID 0000-0002-3294-1441
Giulia PalermoDepartment of Bioengineering, University of California Riverside, 900 University Avenue, Riverside, California 52512, United States.ORCID 0000-0003-1404-8737

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expanding the range of Protospacer Adjacent Motifs (PAMs) recognized by CRISPR-Cas9 is essential for broadening genome-editing applications. Here, we combine molecular dynamics simulations with graph-theory and centrality analyses to dissect the principles of PAM recognition in three Cas9 variants - VQR, VRER, and EQR - that target noncanonical PAMs. We show that efficient recognition is not dictated solely by direct contacts between PAM-interacting residues and DNA but also by a distal network that stabilizes the PAM-binding domain and preserves long-range communication with REC3, a hub that relays signals to the HNH nuclease. A key role emerges for the D1135 V/E substitution, which enables stable DNA binding by K1107 and preserves key DNA phosphate locking interactions via S1109, securing stable PAM engagement. In contrast, variants carrying only R-to-Q substitutions at PAM-contacting residues, though predicted to enhance adenine recognition, destabilize the PAM-binding cleft, perturb REC3 dynamics, and disrupt allosteric coupling to HNH. Together, these findings establish that PAM recognition requires local stabilization, distal coupling, and entropic tuning, rather than a simple consequence of base-specific contacts. This framework provides guiding principles for engineering Cas9 variants with expanded PAM compatibility and improved editing efficiency.

Indexed as

CRISPR-Associated Protein 9CRISPR-Cas SystemsDNAGene EditingMolecular Dynamics SimulationCRISPR-Associated Protein 9DNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.